Concepedia

Sean D. Donevan

SD

31

Publications

2.7K

Citations

27

H-Index

1988

Active since

Affiliations

National Institutes of Health(Current)

National Institute of Neurological Disorders and Stroke

University of Utah

Pfizer (United States)

Queen's University

Sean D. Donevan is an author at National Institutes of Health specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1988–2015

31

Publications

31

GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses

Sean D. Donevan, Michael A. Rogawski · Neuron · 1993 · 358 citations

, , +11

Intracellular polyamines mediate inward rectification of Ca(2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.

Sean D. Donevan, Michael A. Rogawski · Proceedings of the National Academy of Sciences · 1995 · 231 citations · Full text

, , +21

Direct activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons.

Jong M. Rho, Sean D. Donevan, Michael A. Rogawski · The Journal of Physiology · 1996 · 185 citations · Full text

Mechanism of action of the anticonvulsant felbamate: Opposing effects on <i>N</i>‐methyl‐<scp>D</scp>‐aspartate and γ‐aminobutyric acid<sub>A</sub> receptors

Jong M. Rho, Sean D. Donevan, Michael A. Rogawski · Annals of Neurology · 1994 · 184 citations

, , +21

Acetoacetate, Acetone, and Dibenzylamine (a Contaminant in <scp>l</scp>‐(+)‐β‐Hydroxybutyrate) Exhibit Direct Anticonvulsant Actions in Vivo

Jong M. Rho, Gail D. Anderson, Sean D. Donevan et al. · Epilepsia · 2002 · 154 citations

Rows per page

1–5 of 31